Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8394636rdf:typepubmed:Citationlld:pubmed
pubmed-article:8394636lifeskim:mentionsumls-concept:C0034493lld:lifeskim
pubmed-article:8394636lifeskim:mentionsumls-concept:C0032176lld:lifeskim
pubmed-article:8394636lifeskim:mentionsumls-concept:C0033216lld:lifeskim
pubmed-article:8394636lifeskim:mentionsumls-concept:C1706968lld:lifeskim
pubmed-article:8394636pubmed:issue2lld:pubmed
pubmed-article:8394636pubmed:dateCreated1993-9-15lld:pubmed
pubmed-article:8394636pubmed:abstractTextProcainamide was capable of blocking the alpha 2-adrenergic receptor agonist clonidine-induced platelet aggregation, giving an antagonistic index, pA2, of 5.0 +/- 0.6 and half antagonistic concentration, A2, of 10.4 mumol.L-1. Clonidine showed half efficacy concentrations (EC50) of 44, 82, 182, 485, and 662 nmol.L-1, and affinity parameter (pD2) of 7.4, 7.1, 6.7, 6.3, and 6.2 respectively when different concentrations of procainamide were used as blocking reagent. The results indicated that the mechanism of inhibitory effect of procainamide on clonidine-induced platelet aggregation was to competitively antagonize activating alpha 2-receptors and others of clonidine on platelet membrane.lld:pubmed
pubmed-article:8394636pubmed:languageenglld:pubmed
pubmed-article:8394636pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8394636pubmed:citationSubsetIMlld:pubmed
pubmed-article:8394636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8394636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8394636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8394636pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8394636pubmed:statusMEDLINElld:pubmed
pubmed-article:8394636pubmed:monthMarlld:pubmed
pubmed-article:8394636pubmed:issn0253-9756lld:pubmed
pubmed-article:8394636pubmed:authorpubmed-author:YangJ WJWlld:pubmed
pubmed-article:8394636pubmed:authorpubmed-author:YangS QSQlld:pubmed
pubmed-article:8394636pubmed:authorpubmed-author:ShawC PCPlld:pubmed
pubmed-article:8394636pubmed:issnTypePrintlld:pubmed
pubmed-article:8394636pubmed:volume14lld:pubmed
pubmed-article:8394636pubmed:ownerNLMlld:pubmed
pubmed-article:8394636pubmed:authorsCompleteYlld:pubmed
pubmed-article:8394636pubmed:pagination127-9lld:pubmed
pubmed-article:8394636pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:8394636pubmed:meshHeadingpubmed-meshheading:8394636-...lld:pubmed
pubmed-article:8394636pubmed:meshHeadingpubmed-meshheading:8394636-...lld:pubmed
pubmed-article:8394636pubmed:meshHeadingpubmed-meshheading:8394636-...lld:pubmed
pubmed-article:8394636pubmed:meshHeadingpubmed-meshheading:8394636-...lld:pubmed
pubmed-article:8394636pubmed:meshHeadingpubmed-meshheading:8394636-...lld:pubmed
pubmed-article:8394636pubmed:meshHeadingpubmed-meshheading:8394636-...lld:pubmed
pubmed-article:8394636pubmed:meshHeadingpubmed-meshheading:8394636-...lld:pubmed
pubmed-article:8394636pubmed:meshHeadingpubmed-meshheading:8394636-...lld:pubmed
pubmed-article:8394636pubmed:year1993lld:pubmed
pubmed-article:8394636pubmed:articleTitleBlockage of clonidine-induced platelet aggregation in rabbits by procainamide.lld:pubmed
pubmed-article:8394636pubmed:affiliationDepartment of Pharmacology, First Military Medical College, Guangzhou, China.lld:pubmed
pubmed-article:8394636pubmed:publicationTypeJournal Articlelld:pubmed